when is retatrutide coming to market Retatrutide, a new weight loss drug not available on the yet, showing promising results in trials. Dr. LaPook explains it’s doing much more than what current medications can. | CBS News The outlook for obesity from
Description
New data on Hengrui Pharma and Kailera Therapeutics investigational oral GLP-1 have validated the late-stage weight loss asset and paved the road for a regulatory submission in China, but analysts pointed to high rates of nausea and vomiting that could challenge the ongoing U.S
Brello is a telehealth platform offering GLP-1 medications through a subscription model with tiered clinical assessments

A routine blood donation alerted Ben to elevated A1C levels, prompting early medical care
Unlike SGLT2 inhibitors (such ...

What do you think: miracle medicine or ticking time bomb

For many women, metabolic health changes with age